Insulin pumps, also called Continuous Subcutaneous Insulin Infusion (CSII), provide better control over diabetes, when compared to other forms of treatment. Insulin pump is a pager-sized battery operated handy device, which is used to deliver insulin through the abdominal wall into the blood stream. The device can be programmed to infuse required dosages of insulin into the patient's body depending on his/her requirements. The pump facilitates 24-hour insulin delivery and is especially useful for diabetics, who witness a fall in blood sugar levels during night, and for those who are not satisfied with the outcome of other methods.

These and other market data and trends are presented in "Insulin Pumps (External): World Market Review" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

1.Methodology
- Study Reliability and Reporting Limitations
- Disclaimers
- Quantitative Techniques & Reporting Level
2.Industry Overview
- Current and Future Analysis
- Competitive Scenario
- Tough Ground for New Entrants
- Major Growth Drivers
- Developments in Insulin Delivering Technologies
- Icr: A Key Factor to Success
- Emergence of Combination Products
- Expiry of Warranty Provides New Opportunities
- Customer Satisfaction
- Issues & Trends
- Debate on Superiority of Pump Therapy over Mdi Continues
- Complicated Software Poses A Threat
- Lack of Awareness Limits Intensive Insulin Therapy Practice
- Teenagers Outdo Adults in Controlling Diabetes
3.Product Facts
4.Corporate Developments
- Animas Partners with Dexcom
- Insulet Inks Agreement with Dexcom
- Medtronic Partners with Lifescan
- Phluid Corporation Inks Agreement with Syprosoft
- Insulet Partners with Flextronics
- Medco Absorbs Polymedica
- Debiotech Allies with Stmicroelectronics
- Nilimedix Seeks Fda Approval
- Nilimedix Attains Ce Approval
- Nationshealth Pockets Diabetes Care & Education
- Spectrx, Inc. Divests Insulin Pump Business
- Roche Launches Accu-Chek Spirit
- Smith Medical Launches Cozmo in China
- Industrial Scholar Devises Wristwatch Insulin Pump
- Medtronic Unveils Arabic Language Insulin Pump
- Medtronic Launches New Diabetes Monitoring System
5.Major Players
- Animas Corporation (USA)
- Debiotech S.A. (Switzerland)
- Disetronic Medical Systems Ag (Switzerland)
- Insulet Corporation (USA)
- Matria Healthcare, Inc. (USA)
- Medtronic Diabetes (USA)
- Nilimedix Ltd (Israel)
- Nipro Diabetes Systems (USA)
- Smiths Medical Md, Inc. (USA)
- Sooil Development Co. Ltd. (Korea)
6.Global Market Anlaytics
7.The United States
- A Major Market for Insulin Delivery Devices
8.Europe
- A.France
- B.Germany
- C.The United Kingdom
- D.Italy
- E.Spain
- F.Rest of Europe
9.Rest of World
- Review of Select Countries/Regions
- Asia-Pacific
- Table 1: Global Insulin Pumps (External) Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 2: Percentage Breakdown of Global Insulin Pumps (External Market by Region for The Years 2008 &
- Table 3: Insulin Pumps (External) Market in The US: 2007-2015 (Sales in US$ Million)
- Table 4: Insulin Pumps (External) Market by Region in Europe: 2007-2015 (Sales in US$ Million)
- Table 5: Percentage Breakdown of Insulin Pumps (External) Market by Region in Europe for The Years 2008 &
- Table 6: Insulin Pumps (External) Market in France: 2007-2015 (Sales in US$ Million)
- Table 7: Insulin Pumps (External) Market in Germany: 2007-2015 (Sales in US$ Million)
- Table 8: Insulin Pumps (External) Market in The UK: 2007-2015 (Sales in US$ Million)
- Table 9: Insulin Pumps (External) Market in Italy: 2007-2015 (Sales in US$ Million)
- Table 10: Insulin Pumps (External) Market in Spain: 2007-2015 (Sales in US$ Million)
- Table 11: Insulin Pumps (External) Market in Rest of Europe: 2007-2015 (Sales in US$ Million)
- Table 12: Insulin Pumps (External) Market in Rest of World: 2007-2015 (Sales in US$ Million)
Companies Profiled

Pharmaceutical Market Research

Insulin Pumps (External)

Insulin Pumps (External)

Contents

Related products